These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2472266)

  • 21. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
    Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T
    Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The lack of generalized immunosuppression in C57BL/6 mice during progressive growth of syngenic T lymphoma EL-4 and Lewis lung carcinoma 3LL].
    Fuks BB; Malaĭtsev VV; Bogdanova IM
    Biull Eksp Biol Med; 1986 Jun; 101(6):725-8. PubMed ID: 3089345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunomodulating action of ceruloplasmin in tumor growth and the participation of cyclic nucleotides].
    Antonenko SG; Berdinskikh NK; Shishko ED; Okolot EN
    Vopr Onkol; 1985; 31(5):48-52. PubMed ID: 4013129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Colony formation efficiency in agar cultures of the bone marrow and spleen from intact mice in diffusion chambers implanted in the abdominal cavity of mice with Lewis pulmonary carcinoma].
    Lepekhina LA
    Eksp Onkol; 1986; 8(1):69-70. PubMed ID: 3948761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Migration capacity of tumor cells treated with immune sera].
    Lebedev KA; Kaulen DR; Khorobrykh VV; D'iakov GN; Simonova AV
    Biull Eksp Biol Med; 1977 Dec; 84(12):712-4. PubMed ID: 597608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of microbial fractions and vehicle on survival of mice bearing Lewis lung carcinoma.
    Richman SP; Chism VT; Murphy SG
    Cancer Treat Rep; 1980; 64(12):1329-33. PubMed ID: 7471123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
    Gorelik E; Segal S; Feldman M
    J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of induced hyperglycemia on metastasis of Lewis pulmonary carcinoma].
    Shmakova NL; Fomenkova TE; Fadeeva TA
    Med Radiol (Mosk); 1991; 36(4):51-3. PubMed ID: 2034090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The components of the blood plasma fibrinolytic system in mice with Lewis lung carcinoma].
    Riabukha VN; Pogorelaia NF; Veksler IG
    Eksp Onkol; 1989; 11(3):78-80. PubMed ID: 2752950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of interferon on the toxic effect and antitumor activity of vinblastine in the combined therapy of metastatic Lewis carcinoma].
    Vorontsova AL; Kudriavets IuI; Fadeev VA
    Eksp Onkol; 1984; 6(6):54-7. PubMed ID: 6084588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
    Isakov N; Feldman M; Segal S
    Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of some synthetic antioxidants on the growth and metastases formation of Lewis lung carcinoma and amelanotic B16 melanoma in C57BL mice.
    Kanclerz A; Zbytniewski Z; Boeryd B
    Arch Geschwulstforsch; 1981; 51(5):379-85. PubMed ID: 7305612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
    Gorelik E
    Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells].
    Chen J; Cao X; Xiu Q
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones.
    Aboud M; Kingsmore S; Segal S
    Nat Immun; 1993; 12(1):17-24. PubMed ID: 8431660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.
    Peppoloni S; Herberman RB; Gorelik E
    Cancer Res; 1985 Jun; 45(6):2560-6. PubMed ID: 2580624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antimetastatic effect of the delta-sleep peptide during stress in mice with Lewis' lung carcinoma].
    Shmal'ko IuP; Mikhaleva II
    Eksp Onkol; 1988; 10(2):57-60. PubMed ID: 2899023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of cyclophosphamide-induced enhancement of experimental metastasis by splenectomy.
    Strzadała L; Rak J; Zioło E; Kuśnierczyk H; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):399-403. PubMed ID: 2639636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in natural killer cells activity in mice bearing subcutaneously implanted Lewis lung carcinoma.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1984; 32(2):185-9. PubMed ID: 6487051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective elimination of lung metastases induced by tumor cells treated with hydrostatic pressure and N-acetyl-L-cysteine.
    Goldman Y; Peled A; Shinitzky M
    Cancer Res; 2000 Jan; 60(2):350-8. PubMed ID: 10667587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.